Abstract 1503P
Background
Spirituality is important in cancer care. Few studies have assessed the spiritual needs (SN) of cancer patients. The purpose of this study was to assess the SN of patients undergoing curative or palliative cancer treatments, and to evaluate the relationship between SN and their health-related quality of life (QOL).
Methods
We conducted a cross-sectional study using a brief questionnaire on the healthcare team's approach to spirituality, the Duke University Religion Index (DUREL), the Functional Assessment of Chronic Illness Therapy Spiritual Well Being Version 4 (FACIT-SP), and the Spiritual Needs Assessment for Patients (SNAP) in outpatient adults with solid tumors undergoing curative-intent or palliative cancer treatments. Informed consent was obtained from all patients.
Results
From March to October/2022, 150 patients were included: 75 receiving curative-intent treatment and 75, palliative. Patients who wanted a spirituality approach by the healthcare team had higher total SN and psychosocial, spiritual, and religious scores than patients who did not want it (p < 0.0001), but lower QOL scores (FACIT-G p = 0.001 and FACIT-SP p = 0.004). SN or QOL did not differ according to treatment intention (p = 0,444 and p = 0,159 respectively), age (r = 0,059), education level (p = 0,999), sex (p = 0,186), or marital status (p = 0,528). There was a predominant weak correlation between SN and QOL (r < 0,4); a moderate negative relationship between emotional well-being and spiritual domain needs (r = -0,416); a weak correlation between SN and the three dimensions of DUREL (r < 0,4); a moderate positive relationship (0,461 < r < 0,616) between faith subscale of spiritual well-being and the three dimensions of DUREL; and also, a moderate positive relationship (r = 0,410) between spiritual well-being and intrinsic religiosity.
Conclusions
In our study, patients who wanted a spiritual approach from the healthcare team had higher SN and lower QOL. SN were not related to cancer treatment intentions or the patient religiosity. Assessment of spirituality may improve cancer care, and further studies could evaluate screening and interventions in this area.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1199P - Developing and systematically validating homologous recombination repair gene detection method based on next-generation sequencing
Presenter: Yi Sun
Session: Poster session 10
1200P - Investigation of multiphoton microscopy as an innovative tool for intraoperative section-free histologic investigations in just a few minutes
Presenter: Martí Homs Soler
Session: Poster session 10
1201P - Novel deep learning model and validation of whole slide images in lung cancer diagnosis
Presenter: Alhassan Ahmed
Session: Poster session 10
Resources:
Abstract
1202P - A deep learning approach using routine pathology images to guide precision medicine in metastatic CRC
Presenter: Chaitanya Parmar
Session: Poster session 10
1203P - Analytical evaluation of whole genome sequencing for acute myeloid leukemia
Presenter: Guidantonio Malagoli Tagliazucchi
Session: Poster session 10
1204P - Real-world utility of whole genome sequencing for patients with cancer: Evaluation of a regional implementation of the 100,000 genomes project
Presenter: Helen Robbins
Session: Poster session 10
1205P - A retrospective machine learning-based analysis of nationwide cancer CGP data across cancer types to identify features associated with recommendation of mutation-based therapy
Presenter: Hiroaki Ikushima
Session: Poster session 10
1478P - Dual single-nucleotide polymorphism biomarker combination to select opioid for cancer pain management
Presenter: Yoshihiko Fujita
Session: Poster session 10
1479P - Use of rescue opioids and pain control after ketamine initiation in refractory cancer pain: A multicentric observational study
Presenter: Pablo Gallardo Melo
Session: Poster session 10
1480P - Long term therapy with denosumab and zoledronic acid: A comparative real-world retrospective observational study on skeletal-related events and pain in patients with metastatic breast cancer
Presenter: Giacomo Massa
Session: Poster session 10